ES2074981T3 - Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos. - Google Patents
Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos.Info
- Publication number
- ES2074981T3 ES2074981T3 ES87311079T ES87311079T ES2074981T3 ES 2074981 T3 ES2074981 T3 ES 2074981T3 ES 87311079 T ES87311079 T ES 87311079T ES 87311079 T ES87311079 T ES 87311079T ES 2074981 T3 ES2074981 T3 ES 2074981T3
- Authority
- ES
- Spain
- Prior art keywords
- treatment
- disorders
- cognoscitive
- cyclic derivatives
- hetero cyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION SE REFIERE AL EMPLEO DE COMPUESTOS QUE ACTUAN COMO ANTAGONISTAS DE 5-HIDROXITRIPTAMINA (5-HT) EN RECEPTORES DE 5-HT3, PARA EL TRATAMIENTO DE DESORDENES DE LA COGNICION TALES COMO DISMINUCION DE LA ATENCION Y DE LA MEMORIA Y ESTADOS DEMENCIALES.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868630077A GB8630077D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB868630076A GB8630076D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB868630074A GB8630074D0 (en) | 1986-12-17 | 1986-12-17 | Medicaments |
GB878707175A GB8707175D0 (en) | 1987-03-25 | 1987-03-25 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2074981T3 true ES2074981T3 (es) | 1995-10-01 |
Family
ID=27449858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES87311079T Expired - Lifetime ES2074981T3 (es) | 1986-12-17 | 1987-12-16 | Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4985437A (es) |
EP (3) | EP0559297B1 (es) |
JP (1) | JP2608079B2 (es) |
AT (2) | ATE152623T1 (es) |
DE (2) | DE3752062T2 (es) |
ES (1) | ES2074981T3 (es) |
GR (1) | GR3017369T3 (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3777805D1 (de) * | 1986-11-21 | 1992-04-30 | Glaxo Group Ltd | Arzneimittel zur behandlung oder vorbeugung des entzugssyndromes. |
US5198447A (en) * | 1986-11-21 | 1993-03-30 | Glaxo Group Limited | Medicaments |
GB8820651D0 (en) * | 1988-09-01 | 1988-10-05 | Glaxo Group Ltd | Medicaments |
AU5650890A (en) * | 1989-05-24 | 1990-12-18 | Nippon Shinyaku Co. Ltd. | Indole derivatives and medicine |
US5171745A (en) * | 1990-07-13 | 1992-12-15 | Du Pont Merck Pharmaceutical Company | Method of treating neurological dysfunction using neutrotransmitter enhancers |
WO1992004347A1 (fr) * | 1990-08-31 | 1992-03-19 | Nippon Shinyaku Co., Ltd. | Derive d'indole et medicament |
HU211081B (en) * | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
EP0492020A1 (en) * | 1990-12-21 | 1992-07-01 | Merrell Dow Pharmaceuticals Inc. | Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders |
IT1250629B (it) * | 1991-07-04 | 1995-04-21 | Boehringer Ingelheim Italia | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. |
EP0688216A1 (en) * | 1993-03-08 | 1995-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Medicament for treating or preventing cerebrovascular diseases |
GB9412995D0 (en) * | 1994-06-28 | 1994-10-26 | Prendergast Kenneth F | Safety enhancing pharmaceutical compositions of an active indazole |
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
AR036041A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
EP1425286B1 (en) * | 2001-09-12 | 2007-02-28 | Pharmacia & Upjohn Company LLC | Substituted 7-aza-[2.2.1]bicycloheptanes for the treatment of diseases |
IL160884A0 (en) | 2001-10-02 | 2004-08-31 | Upjohn Co | Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
US6849620B2 (en) | 2001-10-26 | 2005-02-01 | Pfizer Inc | N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease |
JP2005523288A (ja) * | 2002-02-19 | 2005-08-04 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 疾病治療用の縮合した二環式−n−架橋−複素環式芳香族カルボキサミド |
MXPA04008152A (es) * | 2002-02-19 | 2005-09-08 | Upjohn Co | Compuestos azabiciclicos para el tratamiento de enfermedades. |
EP1478646A1 (en) * | 2002-02-20 | 2004-11-24 | PHARMACIA & UPJOHN COMPANY | Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
BR0315056A (pt) * | 2002-11-01 | 2005-08-16 | Pharmacia & Upjohn Co Llc | Compostos tendo tanto atividade agonista nicotìnica de alfa7 quanto atividade antagonista de 5ht3 para o tratamento de doenças do sistema nervoso central |
GB201421161D0 (en) * | 2014-11-28 | 2015-01-14 | Ge Healthcare As | Metal complex formulations |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI74707C (fi) * | 1982-06-29 | 1988-03-10 | Sandoz Ag | Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror. |
JPS5936675A (ja) * | 1982-07-13 | 1984-02-28 | サンド・アクチエンゲゼルシヤフト | 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド |
FR2557110B1 (fr) * | 1983-12-23 | 1989-11-24 | Sandoz Sa | Nouveaux derives d'amines cycliques, leur preparation et leur utilisation comme medicaments |
EP0189002B1 (en) * | 1984-12-20 | 1993-03-03 | Sandoz Ag | Treatment of gastrointestinal disorders using 5-ht3 antagonists |
CH667657A5 (de) * | 1985-01-07 | 1988-10-31 | Sandoz Ag | Carbocyclische und heterocyclische carbonylmethylen- und methylpiperidine und -pyrrolidine. |
US4605652A (en) * | 1985-02-04 | 1986-08-12 | A. H. Robins Company, Inc. | Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes |
EP0405617A3 (en) * | 1985-03-14 | 1992-11-25 | Beecham Group P.L.C. | Medicaments for the treatment of anxiety |
US4624961A (en) * | 1985-04-17 | 1986-11-25 | A. H. Robins Company, Incorporated | Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes |
EP0200444B1 (en) * | 1985-04-27 | 1992-11-11 | Beecham Group Plc | Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity |
DE3687980T2 (de) * | 1986-01-07 | 1993-06-17 | Beecham Group Plc | Indolderivate mit einer azabicyclischen seitenkette, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zusammensetzungen. |
HU895334D0 (en) * | 1986-07-30 | 1990-01-28 | Sandoz Ag | Process for the preparation of nasal pharmaceutical compositions |
DE3801659A1 (de) * | 1988-01-21 | 1989-07-27 | Boehringer Ingelheim Kg | Tetrahydropyridin - derivate |
CA1332151C (en) * | 1988-01-28 | 1994-09-27 | Roman Amrein | Use of a benzamide to treat cognitive disorder |
EP0342558B1 (en) * | 1988-05-16 | 1994-02-02 | G.D. Searle & Co. | 2-amino-4,5-methyleneadipic acid compounds for treatment of CNS disorders |
YU150489A (sh) * | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
AU647754B2 (en) * | 1989-10-16 | 1994-03-31 | Hem Research, Inc. | Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
DK0456519T3 (da) * | 1990-05-11 | 1994-11-07 | Sankyo Co | Piperidyloxy- og quinuclidinyloxyisoxazolderivater, deres fremstilling og deres terapeutiske anvendelse |
-
1987
- 1987-12-16 DE DE3752062T patent/DE3752062T2/de not_active Expired - Lifetime
- 1987-12-16 ES ES87311079T patent/ES2074981T3/es not_active Expired - Lifetime
- 1987-12-16 AT AT93201171T patent/ATE152623T1/de not_active IP Right Cessation
- 1987-12-16 JP JP62318458A patent/JP2608079B2/ja not_active Expired - Lifetime
- 1987-12-16 EP EP93201171A patent/EP0559297B1/en not_active Expired - Lifetime
- 1987-12-16 EP EP19930200775 patent/EP0551963A3/en not_active Withdrawn
- 1987-12-16 EP EP87311079A patent/EP0279990B1/en not_active Expired - Lifetime
- 1987-12-16 DE DE3751404T patent/DE3751404T2/de not_active Expired - Lifetime
- 1987-12-16 AT AT87311079T patent/ATE124865T1/de not_active IP Right Cessation
- 1987-12-16 US US07/133,885 patent/US4985437A/en not_active Expired - Lifetime
-
1995
- 1995-09-13 GR GR950402486T patent/GR3017369T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DE3752062T2 (de) | 1997-09-11 |
EP0279990B1 (en) | 1995-07-12 |
DE3752062D1 (de) | 1997-06-12 |
GR3017369T3 (en) | 1995-12-31 |
JPS63277623A (ja) | 1988-11-15 |
EP0279990A3 (en) | 1990-11-28 |
EP0559297A1 (en) | 1993-09-08 |
DE3751404D1 (de) | 1995-08-17 |
EP0551963A3 (en) | 1993-09-01 |
ATE124865T1 (de) | 1995-07-15 |
US4985437A (en) | 1991-01-15 |
DE3751404T2 (de) | 1995-12-21 |
ATE152623T1 (de) | 1997-05-15 |
EP0551963A2 (en) | 1993-07-21 |
JP2608079B2 (ja) | 1997-05-07 |
EP0279990A2 (en) | 1988-08-31 |
EP0559297B1 (en) | 1997-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2074981T3 (es) | Uso de derivados heterociclicos en el tratamiento de trastornos cognoscitivos. | |
FI931370A (fi) | Kvaeve innehaollande analoger av icke-aromatiska heterocykliska foereningar med en fusionerad ring | |
TR199700749T1 (xx) | 5-HT resept�r antagonisti olarak indole t�revleri. | |
ATE162521T1 (de) | 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen | |
BR9206500A (pt) | Heterociclos contendo, nitrogênio tricíclico condensado como antagonistas de substancia receptora P | |
SE8704746D0 (sv) | Tricykliska ketoner | |
DE3772789D1 (de) | Halogen enthaltende heterozyklische verbindungen und diese enthaltende fluessigkristalline zusammensetzungen. | |
ES2065691T3 (es) | Derivados de quinuclidina. | |
CA2123403A1 (en) | Acyclic ethylenediamine derivatives as substance p receptor antagonists | |
NO964236D0 (no) | Anvendelse av serotonin-antagonister (5HT3) for behandling av fibromyalgi | |
ES2113368T3 (es) | Antagonistas de serotonina. | |
DE3650647D1 (de) | Arzneimittel zur Behandlung von Anxietas | |
DE3788057D1 (de) | Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen. | |
NO871861D0 (no) | Fremgangsmaate for fremstilling av nye dopamin beta-hydroxylase inhibitorer. | |
ATE182467T1 (de) | Verwendung von antagonisten oder partiellen agonisten am 5-ht 1a-rezeptor zur behandlung und prävention von kognitiven störungen | |
ATE95704T1 (de) | Anwendung heterozyklischer derivate zur herstellung von arzneimitteln. | |
FI100240B (fi) | Menetelmä keskushermostoon vaikuttavien substituoitujen syklohekseenie n valmistamiseksi | |
BG103089A (en) | Indoline derivatives useful as 5-ht-2c-receptor antagonists | |
DE68926222D1 (de) | Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 279990 Country of ref document: ES |